HPAPI 2020 conference to discuss containment solutions and ADC developmentsHPAPI Conference Share XHPAPI 2020 conference to discuss containment solutions and ADC developmentshttps://pharmaphorum.com/partner-content/hpapi-2020-conference-to-discuss-containment-solutions-and-adc-developments/
HPAPI 2020 Conference – Programme AnnouncedHPAPI Industry Insights Share XHPAPI 2020 Conference – Programme Announcedhttps://pharmaphorum.com/partner-content/hpapi-2020-conference-programme-announced/
Highly Potent Active Pharmaceutical Ingredients (HPAPI)SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on Share XHighly Potent Active Pharmaceutical Ingredients (HPAPI)https://pharmaphorum.com/events/highly-potent-active-pharmaceutical-ingredients-hpapi/
The Latest Innovations in HPAPI Manufacturing TechnologiesHPAPI Technologies Share XThe Latest Innovations in HPAPI Manufacturing Technologieshttps://pharmaphorum.com/partner-content/the-latest-innovations-in-hpapi-manufacturing-technologies/
The need for a blueprint emergency plan to avoid a HPAPI crisisHPAPI Safety Strategies Share XThe need for a blueprint emergency plan to avoid a HPAPI crisishttps://pharmaphorum.com/partner-content/the-need-for-a-blueprint-emergency-plan-to-avoid-a-hpapi-crisis/
Insights into HPAPI Containment and Banding StrategiesHPAPI USA Updates Share XInsights into HPAPI Containment and Banding Strategieshttps://pharmaphorum.com/partner-content/insights-into-hpapi-containment-and-banding-strategies/
Registration Opens for the Inaugural HPAPI USA ConferenceSMi reports: Registration is now open for the HPAPI USA conference, taking place in Boston on the 21st-22nd Share XRegistration Opens for the Inaugural HPAPI USA Conferencehttps://pharmaphorum.com/partner-content/registration-opens-for-the-inaugural-hpapi-usa-conference/
Highly Potent APIs 2019 Conference: Interview with Bayer PharmaLatest Developments in HPAPI Share XHighly Potent APIs 2019 Conference: Interview with Bayer Pharmahttps://pharmaphorum.com/partner-content/highly-potent-apis-2019-conference-interview-with-bayer-pharma/
HPAPI – Ester Lovsin Barle from Lonza AG discusses the latest issuesHPAPI – Lonza AG interview Share XHPAPI – Ester Lovsin Barle from Lonza AG discusses the latest issueshttps://pharmaphorum.com/partner-content/hpapi-ester-lovsin-barle-from-lonza-ag-discusses-the-latest-issues/